LAFAYETTE – Cancer Center of Acadiana (CCA) at Lafayette General Medical Center
(LGMC) is seeking men and women ages 18 and older diagnosed with Stage 4 non-small cell lung cancer who are positive for EGFR sensitizing mutations to participate in a clinical trial.
This research will evaluate the effectiveness of an investigational treatment when combined with a commercially available treatment used for a variety of cancers, including non-small cell lung cancer. This study will determine effectiveness in terms of progression-free survival in subjects who have previously untreated metastatic EGFR-mutated non-small cell lung cancer and a BDX004 Positive Label.
The Lung Mass Clinic at CCA is the state’s only dedicated lung diagnostic testing center. It has a group of physicians dedicated to handling potential lung cancer cases, offering patients access to the largest range of diagnostic testing available under one roof in Louisiana.
CCA participates in clinical trials and studies to help improve patient care. Clinical trials can help to expand knowledge about ways to treat cancer.
Clinical trials also empower a patient who may not be responding ideally to treatment to make his or her own decision. Physicians, nurses and other team members at CCA will thoroughly instruct a patient on potential risks and benefits of participating in a clinical trial. The staff will then closely monitor and assess the patient and continue this through follow-up care.
When patients participate in a clinical trial, they are not only advancing medical technology, they are providing a valuable benefit to future generations. The goal of clinical trials at Lafayette General Medical Center is to support the patient-centered approach to health care.
For more information on this and other clinical trials available at Lafayette General Medical Center, call (337) 289-8658.
About Lafayette General Medical Center
Lafayette General Medical Center (LGMC) staffs a total of 365 beds and is the largest fullservice, acute-care medical center in the nine-parish area of Acadiana. LGMC provides families with comprehensive medical services at every level of care.
Lafayette General has the busiest emergency department in Acadiana and handles the highest level of trauma in the region. The hospital’s 32-bed adult intensive care unit (ICU) is staffed 24/7 by intensivists (physicians specializing in critical care), while the 25-bed neonatal intensive care unit (NICU) boasts benchmark status in Key Performance Indicators by the Vermont Oxford Network. The Medical Center evolved from Lafayette Sanitarium, a six-bed facility that opened in 1911,
and has been a leader in health care throughout its existence. Over the years, LGMC has expanded its services and facilities to meet the community’s growing needs, having been named a Center of Excellence in Minimally Invasive Gynecology and in Neuroscience, as well as having the distinction as an Accredited Cancer Program, Advanced Certified Primary Stroke Center, Disease-Specific Care Certification for Joint Replacement Hip and Knee and Accredited Center for Metabolic and Bariatric Surgery. A leader in technology, LGMC was the first to bring the da Vinci® (a robotic surgical system), CyberKnife® (a stereotactic radiosurgery system), MAKOplasty® (an orthopedic surgery robotic arm), and Medtronic O-Arm (a surgical imaging system) to Acadiana. Lafayette General Medical Center is recognized by federal and state tax laws as a 501c(3) not-for-profit corporation. As a community-owned and managed hospital, all decisions are made locally by an experienced administrative team and a volunteer Membership Corporation and Board of Trustees. For more information about LGMC and its affiliates, visit LafayetteGeneral.com.